Clin2
NCT06478290Possibly a fitNot yet recruiting

Curcumin, omega-3, and vitamin D for people with RA antibodies

Healthy Participants

Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.

This trial tests whether taking a combination of curcumin, omega-3, and vitamin D supplements is safe for people who have antibodies linked to rheumatoid arthritis (called ACPA). It may help reduce inflammation and delay disease onset.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must have tested positive for ACPA antibodies in your blood.
  • You need to be between 18 and 65 years old.
  • You must take the study supplements daily for 84 days (about 3 months).
  • If you are a woman who could become pregnant, you need to use birth control during the trial.
  • You cannot take blood thinners like warfarin, and you must not have had an infection or vaccine in the last 4 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06876064Not yet recruiting
National study of people at risk for rheumatoid arthritis

This study follows people who are at high risk for developing rheumatoid arthritis, as well as first-degree relatives of RA patients and people with very early untreated RA. It aims to learn more about the disease so doctors can better predict and prevent it.

Montpellier, Hérault
NCT06881966Not yet recruiting
Omega-3 fatty acids for rheumatoid arthritis

This trial tests if taking omega-3 supplements (like fish oil) can help reduce inflammation and symptoms in people with rheumatoid arthritis. It is looking for adults diagnosed with RA who are not allergic to fish or seafood and do not have certain other health conditions.

Tunis, Bab Saadoun
NCT06671054Recruiting· Phase 2
Testing AP1189 for newly diagnosed active rheumatoid arthritis

This study tests an oral drug called AP1189 for people just diagnosed with active rheumatoid arthritis who haven't yet taken standard arthritis medicines. You may be able to take part if your disease is very active and you're ready to try a new treatment option.

Cutler Bay, Florida
NCT07276581Recruiting· Phase 2
Testing AZD1163 for active rheumatoid arthritis

This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.

Glendale, Arizona
NCT06758817Recruiting
Nutrition, gut health, and rheumatoid arthritis study

This trial tests if a specific diet can improve your rheumatoid arthritis symptoms by affecting your gut bacteria. You may be eligible if you have active RA and are willing to follow a special meal plan for several weeks.

Lisbon, Portugal
NCT05626348Recruiting· Phase 4
Test immune-modulator treatments for rheumatoid arthritis with knee trouble

This Phase 4 trial studies whether immune-modulator medicines improve symptoms and function in people with rheumatoid arthritis who have knee problems. It may also compare responses in osteoarthritis and healthy volunteers, depending on the group you fit.

Jinan, Shandong

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.